SYK
NYSESTRYKER CORP
Technology · Surgical & Medical Instruments & Apparatus
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$17.1B
2021
$18.4B
2022
$20.5B
2023
$22.6B
2024
$25.1B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$25.1B
Net Income$3.2B
Gross Profit$16.1B
Oper Income$4.9B
EPS (dil)$8.40
Rev/sh$65.52
FCF/sh$11.17
Book/sh$58.48
Gross M64.0%
Oper M19.5%
Profit M12.9%
FCF M17.1%
ROE14.5%
ROA6.8%
ROIC10.3%
R&D/Rev6.5%
Rev Y/Y11.2%
Rev 3Y CAGR10.8%
EPS Y/Y8.2%
EPS 3Y CAGR10.8%
FCF 3Y CAGR28.1%
Payout40%
Div/sh$1.56
Shs Chg Y/Y+0.2%
Current Ratio1.89
Quick Ratio1.21
Debt/Eq0.71
Int Coverage8.1×
Net Debt$11.8B
Total Debt$15.9B
Cash & Eq$4.0B
Total Assets$47.8B
Oper CF$5.0B
Capex$761.0M
Free CF$4.3B
Buybacks$0
Equity$22.4B
Liabilities$25.4B
Shs Outstand0.38B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $17.1B | $18.4B | $20.5B | $22.6B | $25.1B |
| Gross Profit | $11.0B | $11.6B | $13.1B | $14.4B | $16.1B |
| Operating Income | $2.6B | $2.8B | $3.9B | $3.7B | $4.9B |
| Net Income | $2.0B | $2.4B | $3.2B | $3.0B | $3.2B |
| Diluted EPS | $5.21 | $6.17 | $8.25 | $7.76 | $8.40 |
| Operating Cash Flow | $3.3B | $2.6B | $3.7B | $4.2B | $5.0B |
| Free Cash Flow | $2.7B | $2.0B | $3.1B | $3.5B | $4.3B |
COMMUNITY · $SYK0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.